Anti-Human IL5 Recombinant Antibody (TAB-136) (CAT#: TAB-136)
Recombinant monoclonal antibody to IL5. It is a humanized monoclonal antibody intended for the treatment of eosinophil-meditated inflammations of the airways, skin and gastrointestinal tract.
Specific Inquiry
Custom Production
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
We require custom production
RNA Expression
Figure 1 RNA cell line category: Cell line enhanced (Hep G2, TIME)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000113525-IL5
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000113525-IL5
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Rat
- Derivation
- Humanized (from rat)
- Type
- IgG4
- Specificity
- Tested positive against native human antigen.
- Species Reactivity
- Human
- Applications
- Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, IHC and most other immunological methods.
- Related Disease
- Adult eosinophilic asthma
Product Property
- Purity
- >95.0% as determined by analysis by SDS-PAGE.
- Storage
- Store at -20°C for long-term storage. Store at 2-8°C for up to one month. Avoid freeze/thaw cycles.
Target
- Alternative Names
- Reslizumab;cinquil;241473-69-8;SCH 55700;SCH55700;CDP835;CEP-38072;hu39D10;IL5;interleukin 5 (colony-stimulating factor, eosinophil);interleukin-5;B cell differentiation factor I;EDF;eosinophil differentiation factor;IL 5;interleukin 5;T cell replacing fa
- Gene ID
- 3567
- UniProt ID
- P05113
Related Resources
Please refer to Reslizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Reslizumab.
Asthma
Inflammatory Bowel Diseases
Autoimmune Thyroid Disease
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "IL5"
Select a product category from the dropdown menu below to view related products.
Please select product type
Humanized Antibodies
Neutralizing Antibodies
Blocking Antibodies
ScFv Antibodies
Fab Antibodies
ADCC Enhanced Antibodies
IgG Antibodies
FC Reagents & Kits
ScFv-Fc Chimeras
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-031 | Anti-Human IL5 Recombinant Antibody (TAB-031) | IF, IP, Neut, FuncS, ELISA, FC, ICC | IgG1 - kappa |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-136. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: ELISA, FC, IP, FuncS, IF, Neut, WB
-3.jpg)
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
